In Vitro Technologies are the premier supplier for cell biology and translational research throughout Australia and New Zealand.
Our range of cells, consumables, reagents and laboratory equipment support your cell biology workflow in the fields of Cancer, Neuroscience, Immunology, Diabetes & Obesity, Cardiology, Pharmacology, and Drug Discovery. By partnering with world-class suppliers, In Vitro Technologies enables high quality, reproducible data, allowing researchers to accelerate discovery and publish high impact papers.
Our mission is to accelerate discovery into ground breaking Australian research. We strive to support your research by providing world leading products and extensive applications support to aid in the generation of fast, high quality, reproducible data, allowing high impact publications. Accelerate your discovery with In Vitro Technologies.
Mala has a PhD in Medical Science from Monash University where she investigated the Contraceptive Potential of Cysteine Rich Secretory Proteins in the Male Reproductive System, using and models, following several years of experience as an academic lecturing Physiology. She also holds a MBA from The University of Luton in the UK.
Mala is now the National Sales Manager for the life Science team at In Vitro Technologies and is responsible for the employment, training, mentoring and management of the Life Science Territory Management team to ensure they provide the best service, support and technical assistance to medical researchers in the Australian market
m: 0401 204 887
Lorraine has a Bachelor of Science from the University of Auckland and has over 14+ years’ experience within the Life Science and Healthcare industry. Lorraine first joined the In Vitro Technologies NZ Team in 2013 as the Life Science Product Manager for our Cell Culture portfolio. Since then Lorraine has moved into a management role and now manages the New Zealand Sales & Operations Team across our Life Science, Medical and Diagnostic divisions.
As the New Zealand Country Manager it is Lorraine’s responsibility to ensure we are constantly delivering the best possible service to all of our customers across all divisions. Lorraine enjoys working closely with our Customers, Territory Managers and Product Managers to ensure this service is reflected in our performance. We understand the importance of great customer service and delivering high quality products to our customers.
Phone: +64 21 709 142
Steve joined the In Vitro Technologies team early 2017 to product manage the Animal Care and Lab Equipment portfolios. Steve has a strong business acumen and is a results and customer-driven team leader with senior business and product development experience expanding more than 20 years.
Based in Sydney Steve is responsible for sales, facility design and support for the In Vitro Technologies “Animal Care & General Laboratory Equipment portfolios.
Steve was recently appointed Sales Manager – Life Science Equipment and is also responsible for the employment, mentoring and leadership of the Life Science Equipment sales specialist team ensuring that we provide the very best service, support and to our customers in the Australian & New Zealand markets
p: 0466 744 810
David Liuwantara is a product manager in the In Vitro Technologies Life Science division, responsible for the promotion and support of Bio-Techne products and Agilent Seahorse Bioanalyzer, to researchers and clinicians in the ANZ region. With solid problem solving skills and a strong technical background, as well as an outgoing personality, David values long term relationship over short term gain, always seeking a "win-win" solution for the best interest of all parties involved.
David has over 10 years of laboratory experience as a research scientist with expertise in the area of immunology, diabetes, hematology, and cell transplantation; as well as over 3 year of experience supporting capital equipment at the Westmead Institute. In addition to this, David also has 4+ years experience working in a clean room facility following GMP standard and TGA guidelines, to manufacture islet cells for human transplantation as cell therapy to cure type-1 diabetes.
After working on a variety of projects at the University of Queensland, Masuda joined In Vitro Technologies in 2016 as a Life Science Territory Manager. Building on her experience and interest in Bioproduction, Masuda is now also responsible for the marketing, sales and application support of the In Vitro Technologies Bioproduction portfolio, including Infors HT and Protein Ark, working with customers to ensure reproducible, high yield bacterial or mammalian cultures.
p: 07 3219 0022
Sanket holds PhD in cancer cell biology from the University of Sydney followed by five years’ post-doctoral experience at Cancer Research UK - Beatson Institute and UNSW, Australia. During this time, he researched on characterising novel therapeutic targets within the areas of cell division cycle, immuno-oncology and cancer metabolism. Sanket has first and co-authored peer-reviewed articles in high impact scientific journals such as Molecular Cancer Therapeutics, Nature Cell Biology, PNAS USA and Cell. Recently, Sanket worked in a client-facing role at the ACRF Drug Discovery Centre (CCIA) where he delivered fee-for-service projects for academics, clinicians and biotech companies.
Sanket joined the In Vitro team in November 2018 as a Life Science Territory Manager for NSW and ACT. Sanket is the main point of contact for customers within his territory. His responsibilities include managing existing accounts and actively following up new opportunities for further business development. Sanket is passionate about hearing your exciting research. His extensive experience in translational medical research together with a broad range of In Vitro products can help you attain publication quality results faster for high impact peer-reviewed journals.
Sanket is our product manager for ATCC, Ployplus & TerumoBCT
P: 02 9879 0755
Frances completed an Associate Diploma of Pathology at Sydney Technical College followed by a Master of Science in Medicine from Sydney University. Her research career focused in 2 areas: 1. The detection of PAPP-A protein as an early screening tools for Downs Syndrome in pregnancy. 2. Diabetic responses to transplantation and grafting of tissue, looking at the immunological effects. Published articles in both the Journal of Obstetrics, Gynaecology & Reproductive Biology and Cell Transplantation.
Frances is based in Sydney NSW and has been long a serving employees with In Vitro Technologies starting her career at Medos company in 1997. In Vitro Technologies acquired Medos Company in 2005 and during her years Frances has been a Territory Manager, Product Manager and an Equipment Specialist Life Science team.
Frances is responsible for the management of NSW life science equipment Sales, Training of customers face to face, Building relationships and offering the best Service, Support and Technical Assistance to the Life Science Researchers in NSW.
p: 0421 585 840
Daniel completed a Bachelor of Honours in Pharmacology at University of Auckland Faculty of Medical and Health Science, his research focused on the regulation of glycosylation via calcium in neuronal maturation After which within the department of Anatomy he work on characterising the distribution and identity of stem cells in the human brain.
Daniel is based in Auckland and has been with In Vitro Technologies for two years starting in a Life Science Sales Support role before moving into a Territory Management role for the Upper North Island looking after our equipment and consumables portfolios. He is committed to providing the best technical and sales support to those at the bench to help with the unique challenges faced by NZ scientists.
M: 027 582 2348
Jane completed a Bachelor of Medical and Pharmaceutical Biotechnology followed by an honours degree in Nano- & Bio-Materials at the University of South Australia. She recently completed her PhD thesis dissertation at University of Technology Sydney where she studied the treatment of obesity-related metabolic disorders using gold nanoparticles. Her research focused in the therapeutic potential of nanoparticles and the complex nanoparticle-biological interactions at the cellular and molecular levels.
Jane is based in Sydney NSW and has recently joined the In Vitro Technologies family as a Scientific Territory Manager in the Life Science division. She is responsible for customer relation management, actively planning and prospecting for new business opportunities and building rapport with existing clients within her territory.
Jane's role will also entail the sales of consumables and equipment, supporting the equipment specialist, Frances Casamento. Her interdisciplinary skill and expertise in cell biology, molecular biology, material science, chemistry allowed her to support researchers with appropriate resources and information. She is also customers primary contact, following up on enquires and complaint resolution.
m: 0429 511 731
Rehen completed Post graduation studies in Biotechnology and Bioinformatics at La Trobe University where his research was focused on identifying novel inhibitors for Necroptotic regulators using a yeast- based screening.
He joined In Vitro Technologies in 2017 as a Support Specialist in the Life Science division, and in 2018 moved into a Territory Management position in which he aims to provide advanced scientific and technical support to Life Science researchers across Victoria.
p: 0466 744 819
Sing-Yee completed a Bachelor of Science (Chemistry) followed by an honours degree at the University of Western Australia. She later moved to Sweden for a PhD in Biomedical Sciences at Malmo University. Her research focused on developing small molecule libraries for drug therapy, biosensor fabrication and surface modification suitable for cell biology work.
Since the completion of her degree, she has returned to Perth WA and has recently joined the company as a Life Science Territory Manager.
Meryl completed her PhD at the University of Auckland before undertaking post-doctoral research at the University Of Leeds, UK. Her research focused on understanding how pathogenic RNA viruses replicate and using structure-based drug design to target essential replication proteins. She is experienced in a range of structural and molecular techniques.
Meryl joined In Vitro Technologies in 2017 and is based in Auckland. She started as a Life Science support specialist and is now a Territory Manager helping researchers in the Lower North Island.
p: 0800 468 487
Rocio completed a Degree in Dental Surgery and a Master’s degree in Dental Science at Autonomous University of Mexico State. She also completed her PhD in Immunology at QIMR Berghofer Medical Research Institute-Griffith University. Her research focused in the screening, identification, testing and synthesis of compounds that enhance human immune function.
After completing her studies, she undertook a temporary position as a research officer at QIMR. She has recently joined the company as life sciences territory manager QLD.
p: 07 3219 0022
Katelyn completed a Bachelor of Biomedical Science followed by honours at Deakin University where she focused on the regulation of gene expression in breast cancer cells.
She became part of the In Vitro Technologies team in 2017 as a Life Science Support Specialist and provided scientific as well as technical support to the consumables portfolio across Australia. She is now a Territory Manager and supports the needs of researchers across Victoria and Tasmania.
m: 03 9771 3794
Kislay completed M.Sc in Applied Microbiology in India with research on plant derived bioactive compounds against infectivity and propagation of Hepatitis E virus. He then moved to Deakin Uni Australia in 2010 to pursue my PhD in targeting cancer cell death using nanoformulated recombinant proteins. Kislay gained experience in lecturing and student supervision during the 5 years of postdoctoral research career with focusses on nanomedicine and brain metastasis.
Kislay joined in Vitro in August 2018 as a life science support specialist and was moved into a team lead role in April 2019. During this period he undertook sales training and gained sales support experience.